Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography - PubMed (original) (raw)

. 1987 Nov 15;47(22):6052-7.

Affiliations

PMID: 3664507

Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography

C W Daniel et al. Cancer Res. 1987.

Abstract

17 beta-Estradiol is a recognized mammary mitogen, but uncertainty exists as to whether its normal action is mediated exclusively through the pituitary or whether in addition direct effects of estradiol on mammary tissue may play a role in mammary growth and development. To further investigate the action of estradiol on the developing mammary ductal system of young mice, implants of biocompatible ethylene vinyl acetate copolymer, which deliver small amounts of steroid locally to the target tissue, were implanted into the mammary glands of castrated females in which the ductal system was static and end buds had regressed. Within 3 days end buds appeared in the vicinity of the implants but not elsewhere in the gland and not in other glands of the animal, indicating direct stimulation. The new end buds were histologically normal, displaying a visible cap (stem) cell layer with high levels of DNA synthesis. The antiestrogen keoxifene, which competes with estrogen for its receptors, inhibited end bud formation in the estradiol-implanted gland but failed to inhibit growth when implanted into the glands of intact, 5-week-old females. Time course and dose-response studies of estradiol stimulation were carried out in ovariectomized animals and were consistent with a direct action for estrogen. Steroid autoradiography revealed estrogen receptors in the lumenal cells of the end bud, in ductal epithelium, and in stroma adjacent to ducts, but none was detected in the rapidly proliferating cap cells. We conclude that estrogen, perhaps acting on nonepithelial target cells and probably in conjunction with extramammary factors, directly stimulates mammary ductal growth.

PubMed Disclaimer

Cited by

Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma.
Motta JM, Hassan H, Ibrahim SA. Motta JM, et al. Cancers (Basel). 2023 Mar 16;15(6):1794. doi: 10.3390/cancers15061794. Cancers (Basel). 2023. PMID: 36980680 Free PMC article. Review.
Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis.
Porras L, Ismail H, Mader S. Porras L, et al. Cells. 2021 Oct 31;10(11):2966. doi: 10.3390/cells10112966. Cells. 2021. PMID: 34831189 Free PMC article. Review.
Estrogen receptor-α signaling in post-natal mammary development and breast cancers.
Rusidzé M, Adlanmérini M, Chantalat E, Raymond-Letron I, Cayre S, Arnal JF, Deugnier MA, Lenfant F. Rusidzé M, et al. Cell Mol Life Sci. 2021 Aug;78(15):5681-5705. doi: 10.1007/s00018-021-03860-4. Epub 2021 Jun 22. Cell Mol Life Sci. 2021. PMID: 34156490 Free PMC article. Review.
Benzophenone-3 promotion of mammary tumorigenesis is diet-dependent.
Kariagina A, Morozova E, Hoshyar R, Aupperlee MD, Borin MA, Haslam SZ, Schwartz RC. Kariagina A, et al. Oncotarget. 2020 Dec 1;11(48):4465-4478. doi: 10.18632/oncotarget.27831. eCollection 2020 Dec 1. Oncotarget. 2020. PMID: 33400736 Free PMC article.
Single-cell RNA-sequencing analysis of estrogen- and endocrine-disrupting chemical-induced reorganization of mouse mammary gland.
Kanaya N, Chang G, Wu X, Saeki K, Bernal L, Shim HJ, Wang J, Warden C, Yamamoto T, Li J, Park JS, Synold T, Vonderfecht S, Rakoff M, Neuhausen SL, Chen S. Kanaya N, et al. Commun Biol. 2019 Nov 5;2:406. doi: 10.1038/s42003-019-0618-9. eCollection 2019. Commun Biol. 2019. PMID: 31701034 Free PMC article.

Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography - PubMed (original) (raw)